Rabi Hanna, MD, from the Department of Pediatric Hematology Oncology and BMT at Cleveland Clinic…

At ASH 2023, Hamza Hashmi, MD, a medical doctor and hematologist from Charleston, South Carolina,…

By: Melinda Telli, MD, Date: 12/9/2023 At the SABCS 2023 conference, we had the privilege…

Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…

Allen Wilbanks stands at the forefront of SABCS 2023, the setting for a conversation with…

By. Terry Mamounas Date: 12/07/2023In a collaborative study between NVP and RT, led by oncologist…

In the groundbreaking study conducted by Bruce Feinberg,DO, Chief Medical Officer at Cardinal Health, the…

In an interview, Andrew Evens, DO, an expert in hematology and oncology, will discuss a…

In this ASH 2023 interview, Dr. Jos Melenhorst discusses a collaborative study on single-cell multi-omics…

Allen Wilbanks finds himself at SABCS 2023, where he engages in a discussion with Dr.…